HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making
About this episode
Dr. Seth Wander discusses the role of biomarker assessment in managing HR-positive metastatic breast cancer.
Dr Seth Wander from Massachusetts General Hospital in Boston discusses the role of biomarker assessment in the management of HR-positive metastatic breast cancer. CME information and select publications here .
More episodes of Breast Cancer Update
- ER-Positive, HER2-Positive Metastatic Breast Cancer — What Clinicians Want to Know About First-Line and Maintenance Therapy
- Desmoid Tumors — Microlearning Activity 2 with Dr Ravin Ratan
- Diabetology in Breast Cancer — Managing Hyperglycemia in Patients with Breast Cancer Receiving Agents Targeting the PI3K/AKT/PTEN Pathway
- Breast Cancer — 5-Minute Journal Club Issue 2 with Dr Lajos Pusztai: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
- Desmoid Tumors — Microlearning Activity 1 with Dr Ravin Ratan
- Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
Explore listener stats, chart rankings, contacts and more on the Breast Cancer Update podcast page.